Mohamed, R. E., Oyedeji, C. I., Faldowski, R., Kraus, V. B., Huebner, J., Padrick, S., … Strouse, J. J. (2022). Urinary C-Telopeptide of Type II Collagen As a Marker of Avascular Necrosis in Younger and Older Adults with Sickle Cell Disease. In Blood (Vol. 140, pp. 11116–11117). American Society of Hematology. https://doi.org/10.1182/blood-2022-171210

Mohamed, Rania E., Charity I. Oyedeji, Richard Faldowski, Virginia Byers Kraus, Janet Huebner, Stephanie Padrick, Reena Ravi, Arvind Subramaniam, and John J. Strouse. “Urinary C-Telopeptide of Type II Collagen As a Marker of Avascular Necrosis in Younger and Older Adults with Sickle Cell Disease.” In Blood, 140:11116–17. American Society of Hematology, 2022. https://doi.org/10.1182/blood-2022-171210.

Mohamed RE, Oyedeji CI, Faldowski R, Kraus VB, Huebner J, Padrick S, et al. Urinary C-Telopeptide of Type II Collagen As a Marker of Avascular Necrosis in Younger and Older Adults with Sickle Cell Disease. In: Blood. American Society of Hematology; 2022. p. 11116–7.

Mohamed, Rania E., et al. “Urinary C-Telopeptide of Type II Collagen As a Marker of Avascular Necrosis in Younger and Older Adults with Sickle Cell Disease.” Blood, vol. 140, no. Supplement 1, American Society of Hematology, 2022, pp. 11116–17. Crossref, doi:10.1182/blood-2022-171210.

Mohamed RE, Oyedeji CI, Faldowski R, Kraus VB, Huebner J, Padrick S, Ravi R, Subramaniam A, Strouse JJ. Urinary C-Telopeptide of Type II Collagen As a Marker of Avascular Necrosis in Younger and Older Adults with Sickle Cell Disease. Blood. American Society of Hematology; 2022. p. 11116–11117.